Research on the anti-tumor effect of Plumbagin against human highly metastatic large cell lung cancer cell line

Tao YU,Gang LIU,Ling-ling ZU,Wei-qiang WANG,Yong-wen LI

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2012.04.008

2012-01-01

Abstract:OBJECTIVE: To investigate the anti-tumor effect and mechanism of Plumbagin against human highly metastatic L9981 large cell lung cancer cell line. METHODS: Plumbagin in different concentrations were set up to administrate L9981 cell line. MTT test was performed to detect the inhibiting effects against tumor proliferation and IC 50 concentration was identified. The influence of tumor apoptosis was observed by flow cytometry and the inhibiting effect against invasive ability was detected by boyden chamber test. IC 50 group and control group were set up and tumor cells were harvested 6, 24 and 48 h after administration. Real-time PCR was used to detect mRNA expression changes of Bcl-2, Bax, VEGF and CYCD1. RESULTS: MTT test showed obvious inhibiting effects of proliferation in L9981 cell line (F=39.535, P=0.000). IC 50 was 9.0 μmol/L. Plumbagin significantly induced the apoptosis of tumor cells (F=23.671, P=0.000) and showed a significant anti-invasion effect. Mean membrane-spanning cells were 228.17±55.12 and 9.83±3.87 in control group and IC 50 group correspondingly (t=13.598, P=0.000). Down-regulations of Bcl-2, VEGF and CYCD1 were detected and expression of bax gene increased. Significant differences were found between each time point group in all targeted genes (F=13.520, P=0.000; F=15.778, P=0.000; F=10.163, P=0.000; F=18.635, P=0.000). CONCLUSIONS: Plumbagin has displayed the powerful anti-tumor effects against L9981 cell line and it may work via multiple pathways. Plumbagin exhibits the prospect of being an effective drug against large cell lung cancer.